Addendum:

Stephanie A. Toll^1,2,*, Hung N. Tran^3,*, Jennifer Cotter^2,4, Alexander R. Judkins^2,4, Benita Tamrazi^2,5, Jaclyn A. Biegel^2,4, Girish Dhall^1,2, Nathan J. Robison^1,2, Kaaren Waters¹, Palak Patel², Robert Cooper^3,* and Ashley S. Margol^1,2,*

¹Division of Hematology, Oncology and Blood and Marrow Transplantation, Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles, Los Angeles, CA, USA
²University of Southern California Keck School of Medicine, Los Angeles, CA, USA
³Kaiser Permanente Southern California, Los Angeles, CA, USA
⁴Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, CA, USA
⁵Department of Radiology and Imaging, Children’s Hospital Los Angeles, Los Angeles, CA, USA
^*These authors have contributed equally to this work

Published: May 19, 2023

Copyright: © 2023 Toll et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: Signed HIPPA forms from the parents of the 2 patients who were alive at the time of manuscript submission were obtained.

Original article: Oncotarget. 2019; 10:551-557. DOI: https://doi.org/10.18632/oncotarget.26560.